Home > Food & Beverages > Proteins > Animal-Based Proteins > Human Milk Oligosaccharides (HMO) Market

Human Milk Oligosaccharides (HMO) Market Trends

Report ID: GMI6413
Published Date: Aug 2023
Report Format: PDF

Download Free Sample

Human Milk Oligosaccharides Market Trends

There is a growing focus on gut health and its impact on overall well-being. HMOs are recognized for their prebiotic properties, promoting the growth of beneficial gut bacteria, and supporting a healthy gut microbiome. As consumers become more health-conscious, products containing HMOs as gut health enhancers are gaining popularity. HMOs play a vital role in human breast milk and contribute to infant gut health and immune system development.

Consequently, HMOs are being incorporated into infant formulas and baby foods to replicate some of the benefits of breast milk for formula-fed babies. The demand for HMOs in infant nutrition is increasing as parents seek functional ingredients for their babies' health.

Authors: Kiran Pulidindi, Kunal Ahuja

Frequently Asked Questions (FAQ) :

The market size of human milk oligosaccharides reached USD 200 million in 2022 and is estimated to cross USD 1518.8 million by the end of 2032.

Neutral HMO accounted for a market value of USD 122 million in 2022 as the product is known for its anti-adhesive properties, which means it can prevent pathogens from adhering to the intestinal lining.

The U.S. market held over USD 62.72 million revenue in 2022, as the consumers are increasingly focused on health and wellness, seeking products that offer functional benefits.

Glycosyn LLC, ZuChem Inc, Tereos Starch & Sweeteners, Jenica Research Corporation, Novalac, GlycoUniverse GmbH, Biostime International Holdings Limited, Clasado Biosciences.